Clin2
NCT07745751Likely a fitNot yet recruiting

Testing a new drug for safety in healthy volunteers

Safety and Tolerability in Healthy Volunteers

This study tests a new medicine, TRT-448, to see if it is safe and how it works in the body. It is for healthy adults, and results will help decide if the drug should be studied in people with certain conditions later.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
144 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are generally healthy, with no major medical conditions like heart, lung, liver, or kidney disease.
  • Your body mass index (BMI) is between 18 and 32, and you weigh at least 50 kg (unless in the first group, which requires at least 70 kg).
  • You do not have a history of severe allergies or allergic reactions.
  • You have not had surgery or been hospitalized in the past 3 months, and you have no planned surgeries during the study.
  • You have not had cancer in the last 10 years (some early-stage skin or cervical cancers may be okay).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT07748026Not yet recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.

NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07219368Recruiting· Phase 1
Testing a new drug (MT-201) safety in healthy adults

This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.

San Diego, California
NCT07526116Recruiting· Phase 1
Safety study of REGN22044 in healthy adults

This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.

Ghent, Oost-Vlaanderen
NCT06877611Recruiting· Phase 1
Testing the drug S-4321 in healthy volunteers for safety

This trial tests a new drug called S-4321 to make sure it's safe and well-tolerated in healthy people. You would take the drug and have regular check-ups to see how your body handles it.

Bayswater, Victoria

Hear when a new Safety and Tolerability in Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.